Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
0.548
-0.012 (-2.18%)
At close: Feb 21, 2025, 4:00 PM
0.552
+0.004 (0.73%)
After-hours: Feb 21, 2025, 5:40 PM EST
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $12.06 million as of February 21, 2025. Its market cap has decreased by -58.26% in one year.
Market Cap
12.06M
Enterprise Value
10.12M
1-Year Change
-58.26%
Ranking
Category
Stock Price
$0.55
Market Cap Chart
Since March 31, 2014, Ekso Bionics Holdings's market cap has decreased from $250.40M to $12.06M, a decrease of -95.18%. That is a compound annual growth rate of -24.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 12.10M | -9.70% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | -57.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |